T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.6B |
| 2 |
Verizon
VZ
|
+$1.3B |
| 3 |
US Bancorp
USB
|
+$1.26B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.26B |
| 5 |
Lam Research
LRCX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$6.33B |
| 2 |
Tesla
TSLA
|
+$5.64B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$4.91B |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$3.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.7% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 12.71% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
AnaptysBio
ANAB
$1.66B
| $390K | ﹤0.01% |
12,579
+320
| +3% | +$9.04K |
|
2252
Anavex Life Sciences
AVXL
$303M
| $390K | ﹤0.01% |
42,067
+626
| +2% | +$6.69K |
|
2253
Compass
COMP
$10.2B
| $389K | ﹤0.01% |
166,776
-190,982
| -53% | -$501K |
|
2254
Gorman-Rupp
GRC
$2.11B
| $389K | ﹤0.01% |
15,177
+5,308
| +54% | +$140K |
|
2255
Community Trust Bancorp
CTBI
$1.44B
| $388K | ﹤0.01% |
8,457
-2,172
| -20% | -$99K |
|
|
JBIO
2256
Jade Biosciences
JBIO
$1.51B
| $387K | ﹤0.01% |
+378
| New | +$274K |
|
|
BRSL
2257
Brightstar Lottery PLC
BRSL
$2.15B
| $387K | ﹤0.01% |
17,083
+1,335
| +8% | +$28.9K |
|
2258
ZTO Express
ZTO
$17.4B
| $387K | ﹤0.01% |
14,400
| – | – |
|
2259
4D Molecular Therapeutics
FDMT
$609M
| $386K | ﹤0.01% |
17,379
-729
| -4% | -$11.3K |
|
2260
Senseonics Holdings Inc
SENS
$409M
| $384K | ﹤0.01% |
18,637
+1,765
| +10% | +$40.7K |
|
2261
WisdomTree
WT
$3.44B
| $382K | ﹤0.01% |
70,152
+2,248
| +3% | +$11.7K |
|
2262
Mesa Laboratories
MLAB
$633M
| $381K | ﹤0.01% |
2,290
+587
| +34% | +$92K |
|
|
VSTO
2263
DELISTED
Vista Outdoor Inc.
VSTO
| $381K | ﹤0.01% |
15,654
+712
| +5% | +$18.7K |
|
2264
Interface
TILE
$2.24B
| $380K | ﹤0.01% |
38,527
+942
| +3% | +$9.9K |
|
|
SHCR
2265
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $380K | ﹤0.01% |
237,778
+35,634
| +18% | +$66K |
|
2266
Columbus McKinnon
CMCO
$550M
| $378K | ﹤0.01% |
11,649
+447
| +4% | +$13.2K |
|
2267
Scansource
SCSC
$1.06B
| $378K | ﹤0.01% |
12,923
+456
| +4% | +$13.5K |
|
2268
Washington Trust Bancorp
WASH
$767M
| $378K | ﹤0.01% |
8,002
+299
| +4% | +$14.4K |
|
2269
CRA International
CRAI
$1.07B
| $377K | ﹤0.01% |
3,076
+97
| +3% | +$10.7K |
|
2270
Oil States International
OIS
$526M
| $377K | ﹤0.01% |
50,558
-19,640
| -28% | -$122K |
|
2271
Marten Transport
MRTN
$1.24B
| $376K | ﹤0.01% |
19,012
+1,001
| +6% | +$20K |
|
|
ALX
2272
Alexander's
ALX
$1.4B
| $375K | ﹤0.01% |
1,704
-909
| -35% | -$207K |
|
|
ZUO
2273
DELISTED
Zuora, Inc.
ZUO
| $373K | ﹤0.01% |
58,654
+16,166
| +38% | +$114K |
|
|
ROCC
2274
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $373K | ﹤0.01% |
9,228
+138
| +2% | +$5.47K |
|
2275
Lexicon Pharmaceuticals
LXRX
$1.04B
| $371K | ﹤0.01% |
194,113
+838
| +0.4% | +$1.78K |
|
Similar funds
T. Rowe Price Associates's Q4 2022 Portfolio in Review
As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
- T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
- T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
- T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
- T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
- T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
- T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.
Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.